The purpose of the present invention is to provide a novel compound which has retinoid-related orphan receptor γ antagonistic activity and exhibits a remedial effect or prophylactic effect on autoimmune diseases including psoriasis. The present invention provides the anilide derivative (I) shown below or a hydrate thereof or a pharmacologically acceptable salt of either.